IRTC News and Press, iRhythm Technologies Inc. From 03/29/22

SAN FRANCISCO, March 29, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, announced it has amended its existing debt facility with Silicon Valley Bank (the “Amended Credit Fa...

iRhythm Technologies Inc. (NASDAQ:IRTC) traded today at a new 52-week high of $159.69. Approximately 378,000 shares have changed hands today, as compared to an average 30-day volume of 368,000 shares. In the past 52 weeks, iRhythm Technologies Inc. share prices are bracketed by a low of ...

Potential of telemedicine, big data, artificial intelligence, and administrative digitization in the healthcare sector is huge. EDOC has done quite an effective reshuffling of its portfolio. EDOC is on a downward trend, but has strong potential in the long run. For further d...

Medical devices, healthcare equipment and healthcare supplies grew during the pandemic and the sector is expected to grow further. Equally distributed over 86 stocks, XHE is protected from market volatility risk. Higher price multiples provide an indication of investor confidence....

SAN FRANCISCO, March 14, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC) (“iRhythm”), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced that Kevin King will retire from iRhythm’s Board of Direct...

SAN FRANCISCO, Feb. 28, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, announced that the results of the KP-Rhythm2 study , titled “Diagnostic yield, outcome...

Needham has upgraded iRhythm Technologies (IRTC +11.5%) from hold to buy citing management commentary providing confidence on revenue growth. The firm has a $135 price target (~25% upside based on Wednesday's close). "Our scenario analysis suggests upside to IRTC's 2022 revenue guidance, leav...

Gainers: Lantheus (NASDAQ:LNTH) +34%. Evolent Health (NYSE:EVH) +18%. Clover Health (NASDAQ:CLOV) +10%. Liquidia (NASDAQ:LQDA) +10%. iRhythm Technologies (NASDAQ:IRTC) +8%. Losers: Orphazyme (NASDAQ:ORPH) -36%. Rhythm Pharmaceuticals (NASDAQ:RYTM) -24%. Tabu...

Image source: The Motley Fool. iRhythm Technologies, Inc. Common Stock (NASDAQ: IRTC) Q4 2021 Earnings Call Feb 23, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: iRhythm Technologies, Inc. Common Stock (IRTC) Q4 2...

iRhythm Technologies, Inc. (IRTC) Q4 2021 Earnings Conference Call February 23, 2022 4:30 PM ET Company Participants Leigh Salvo - Head, Investor Relations Quentin Blackford - President and Chief Executive Officer Doug Devine - COO & CFO Dan Wilson - EVP of Corporate Strategy and Investor...